Anthropic, the artificial intelligence company, has opened a wet biology lab in the Bay Area, where it will conduct experiments to test its AI models. The lab, run by Eric Kauderer-Abrams, will focus on fundamental biology rather than drug discovery. Anthropic's CEO, Dario Amodei, has previously stated that AI could cure major diseases within the next decade, but also warned of potential risks. The company has launched a Life Sciences Verification Program to provide vetted bio-researchers access to its models and has published reports on protein design and molecular modeling. The juxtaposition of these efforts and the lab has not gone unnoticed, with some questioning the wisdom of AI companies entering the biotech field.